Your browser doesn't support javascript.
loading
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy.
Wang-Bishop, Lihong; Kimmel, Blaise R; Ngwa, Verra M; Madden, Matthew Z; Baljon, Jessalyn J; Florian, David C; Hanna, Ann; Pastora, Lucinda E; Sheehy, Taylor L; Kwiatkowski, Alexander J; Wehbe, Mohamed; Wen, Xiaona; Becker, Kyle W; Garland, Kyle M; Schulman, Jacob A; Shae, Daniel; Edwards, Deanna; Wolf, Melissa M; Delapp, Rossane; Christov, Plamen P; Beckermann, Kathryn E; Balko, Justin M; Rathmell, W Kimryn; Rathmell, Jeffrey C; Chen, Jin; Wilson, John T.
Afiliação
  • Wang-Bishop L; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Kimmel BR; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Ngwa VM; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Madden MZ; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Baljon JJ; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Florian DC; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Hanna A; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Pastora LE; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Sheehy TL; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Kwiatkowski AJ; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Wehbe M; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Wen X; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Becker KW; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Garland KM; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Schulman JA; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Shae D; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Edwards D; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Wolf MM; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Delapp R; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Christov PP; Department of Civil and Environmental Engineering, Vanderbilt University, Nashville, TN 37232, USA.
  • Beckermann KE; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37232, USA.
  • Balko JM; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Rathmell WK; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Rathmell JC; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Chen J; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Wilson JT; Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Sci Immunol ; 8(83): eadd1153, 2023 05 12.
Article em En | MEDLINE | ID: mdl-37146128

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article